Metropolis Healthcare Limited is a leading diagnostic company based in India, providing cutting-edge pathology and laboratory services. Established in 1980 by Dr. Sushil Shah, Metropolis has since expanded its operations to several countries including India, South Africa, Kenya, Mauritius, and Ghana.

The company offers a comprehensive range of clinical laboratory tests and profiles which are used for prediction, early detection, diagnostic screening, confirmation testing as well as monitoring of diseases. These tests cover various medical specialties such as oncology/hematology, endocrinology/metabolism, infectious diseases including COVID-19 testing during this pandemic period among others.

Metropolis leverages innovative technologies like next-generation sequencing (NGS), liquid biopsy techniques for cancer profiling and other advanced molecular diagnostics tools to provide accurate results with quick turnaround times. The use of state-of-the-art equipment ensures precision in diagnosis and aids in the delivery of superior healthcare solutions to patients.

What makes Metropolis stand out from its competitors is their commitment to quality standards – they are accredited by international bodies like College Of American Pathologists (CAP) ensuring high standards of practice across all their laboratories worldwide. They have also collaborated with numerous hospitals and clinics globally for sample collection centers enabling easier access for patients to avail their services.

In recent years there has been an emphasis on preventive healthcare through regular check-ups which has increased demand for diagnostic companies' services; here Metropolis stands at the forefront due to its reputation built over decades offering reliable reports resulting in strong customer trust.